Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project
Shelley Potter(At Bristol), Stuart McIntosh(Queen's University Belfast), Hiroji Iwata(Aichi Cancer Center), Jean L. Wright(University of North Carolina at Chapel Hill), Nicholas Zdenkowski(Lake Macquarie Private Hospital), Alastair M. Thompson(Baylor College of Medicine), Mairead MacKenzie(The Patients Association), Kerry Avery(University of Bristol), Han‐Byoel Lee(Seoul National University Hospital), Jana de Boniface(Karolinska Institutet), Fiorita Poulakaki(Athens Medical Center), Peter Dubsky(Hirslanden Klinik St. Anna), Gustavo Werutsky(European Organisation for Research and Treatment of Cancer), Sanjoy Chatterjee(Tata Medical Center), Karla A. Sepulveda(Baylor College of Medicine), Andrew J. Spillane(Melanoma Institute Australia), Katherine Cowan, Rosina Ahmed(Tata Medical Center), David Dodwell(University of Oxford), Andrea L. Richardson(Brigham and Women's Hospital), Michael Jiang(University of Bristol)
Cited by 12
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
|The Lancet Psychiatry|2020|6k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k